Concr

Private

LondonHealthcare & Life Scienceshttps://concr.co/

Last Round

Grant

Feb 9, 2024

Total Funding Raised

$4.66M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Concr is a techbio company that provides a predictive modelling platform, FarrSight®, to enhance confidence and foresight about the therapeutic efficacy of existing and emerging cancer drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision oncologydigital twinspredictive modelingclinical trial simulationBayesian AItechbiobiomarker discoverydrug developmentin silico trialsdigital histopathologycomputational biologyAI drug discoverytranslational medicinecloud-native platformpatient-level modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concr Comps

Public and private peers based on sector, stage, and business model.

Concr comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Concr Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 9, 2024
Seed	Nov 29, 2023
Seed	Mar 31, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Irina Babina

Chief Executive Officer

Executive Team

Conor Woolfson

Chief Financial Officer

Executive Team

Emre Misirlioglu

Chief Operating Officer

Executive Team

Concr Investors

Notable investors and investment history

Concr investors
Investor	Rounds
Innovate UK	Grant
Deep Science Ventures	Seed
Cambridge Angels	Seed
Cambridge Enterprise	Seed
R42 Group	Seed
Parkwalk Advisors	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 18, 2026
Monthly visitors increased 85% MoM.

View all signals

Concr Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Concr Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concr's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range9

Year Founded2018

Last FundingFeb 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.